New global criteria for improved diagnosis of pediatric sepsis

Diagnosis of sepsis in children has been improved based on new research findings. An international research team co-led by the Luregn Schlapbach from the University and the University Children’s Hospital Zurich harnessed artificial intelligence to analyze data from over 3.5 million children suffering from this life-threatening disease.

Hawthorne Q1 Revenue Declines Sharply

ScottsMiracle-Gro Reports First Quarter Results; Company Well Positioned for 2025 Lawn & Garden Season U.S. Consumer net sales increased 11 percent driven by strong fall

January 29, 2025

Amylyx ventures into metabolic diseases market with $35.1m deal – Pharmaceutical Technology

On 17 June, Amylyx acquired the rights to Eiger Biopharmaceutical’s experimental glucagon-like peptide-1 (GLP-1) receptor antagonist, avexitide, for $35.1m. Avexitide was previously developed for post-bariatric

June 28, 2024

New environmental risk score assesses a person’s risk for developing ALS using blood sample

Over the last decade, research at Michigan Medicine has shown how exposure to toxins in the environment, such as pesticides and carcinogenic PCBs, affect the

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.